You will find a link to the accompanying preliminary pricing supplement for the Securities above and links to the accompanying product supplement and accompanying prospectus for the Securities under “Additional Information about UBS and the Securities” in the preliminary pricing supplement, which you should read and understand prior to investing in the Securities.
UBS has filed a registration statement (including a prospectus as supplemented by a product supplement and the preliminary pricing supplement) with the Securities and Exchange Commission (the “SEC”) for the offering to which this communication relates. Before you invest, you should read the accompanying prospectus in that registration statement and the other documents the issuer has filed with the SEC, including the accompanying preliminary pricing supplement, and the accompanying product supplement, for more complete information about the issuer and this offering. You may get these documents for free by visiting EDGAR on the SEC website at www.sec.gov. Alternatively, the issuer, any underwriter or any dealer participating in the offering will arrange to send you the prospectus if you request it by calling toll-free 1-833-653-0401. Our Central Index Key, or CIK, on the SEC web site is 0001114446.
Selected Risk Considerations
The risks set forth below are discussed in more detail in the “Key Risks” section in the preliminary pricing supplement. Please review those risks, along with the additional risks discussed in the accompanying product supplement and accompanying prospectus, before making an investment decision.
Risks Relating to Return Characteristics
♦Risk of loss at maturity - The Securities differ from ordinary debt securities in that UBS will not necessarily repay the principal amount of the Securities at maturity. If UBS does not elect to call the Securities, the underlying return is negative and the final level is less than the downside threshold, you will be exposed on a leveraged basis to the decline of the final level from the initial level. Specifically, you will lose.1.25% of your principal amount for each 1% that the final level is less than the initial level in excess of the threshold percentage and, in extreme situations, you could lose all of your initial investment. The contingent repayment of principal applies only if you hold your Securities to maturity
♦The call return and upside gearing apply only upon an issuer call and at maturity, respectively
♦No interest payments
♦If UBS elects to call the Securities prior to maturity on the observation date, your potential return on the Securities will be limited to the call return and you will not participate in any appreciation of the underlying asset or any underlying constituent
♦A higher call return rate or lower downside threshold may reflect greater expected volatility of the underlying asset, and greater expected volatility generally indicates an increased risk of loss at maturity
♦UBS may elect to call the Securities prior to maturity and the Securities are subject to reinvestment risk
♦Owning the Securities is not the same as owning the underlying constituents
♦An investment in Securities with call return and issuer call features may be more sensitive to interest rate risk than an investment in securities without such features
Risks Relating to Characteristics of the Underlying Asset
♦Market risk
♦There can be no assurance that the investment view implicit in the Securities will be successful
♦Changes affecting the underlying asset, including regulatory changes, could have an adverse effect on the market value of, and return on, your Securities
♦UBS cannot control actions by the index sponsor and the index sponsor has no obligation to consider your interests
♦The Russell 2000® Index reflects price return, not total return
♦The Securities are subject to small-capitalization stock risks
Estimated Value Considerations
♦The issue price you pay for the Securities will exceed their estimated initial value
♦The estimated initial value is a theoretical price; the actual price at which you may be able to sell your Securities in any secondary market (if any) at any time after the trade date may differ from the estimated initial value
♦Our actual profits may be greater or less than the differential between the estimated initial value and the issue price of the Securities as of the trade date
Risks Relating to Liquidity and Secondary Market Price Considerations
♦There may be little or no secondary market for the Securities
♦The price at which UBS Securities LLC and its affiliates may offer to buy the Securities in the secondary market (if any) may be greater than UBS’ valuation of the Securities at that time, greater than any other secondary market prices provided by unaffiliated dealers (if any) and, depending on your broker, greater than the valuation provided on your customer account statements
♦Economic and market factors affecting the terms and market price of Securities prior to maturity
♦Impact of fees and the use of internal funding rates rather than secondary market credit spreads on secondary market prices
Risks Relating to Hedging Activities and Conflicts of Interest
♦Potential UBS impact on price
♦Potential conflicts of interest
♦Potentially inconsistent research, opinions or recommendations by UBS
Risks Relating to General Credit Characteristics
♦Credit risk of UBS
♦The Securities are not bank deposits
♦If UBS experiences financial difficulties, FINMA has the power to open restructuring or liquidation proceedings in respect of, and/or impose protective measures in relation to, UBS, which proceedings or measures may have a material adverse effect on the terms and market value of the Securities and/or the ability of UBS to make payments thereunder
Risks Relating to U.S. Federal Income Taxation
♦Uncertain tax treatment — Significant aspects of the tax treatment of the Securities are uncertain. You should consult your tax advisor about your tax situation. See “What Are the Tax Consequences of the Securities?” in the preliminary pricing supplement and “Material U.S. Federal Income Tax Consequences”, including the section “— Securities Treated as Prepaid Derivatives or Prepaid Forwards”, in the accompanying product supplement.